Global Cholesterol Screening Market Growth (Status and Outlook) 2023-2029

Global Cholesterol Screening Market Growth (Status and Outlook) 2023-2029

The elevated levels of cholesterol create health threats such as sharp risk of stroke & heart diseases and account for a large number of deaths.

LPI (LP Information)' newest research report, the “Cholesterol Screening Industry Forecast” looks at past sales and reviews total world Cholesterol Screening sales in 2022, providing a comprehensive analysis by region and market sector of projected Cholesterol Screening sales for 2023 through 2029. With Cholesterol Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cholesterol Screening industry.

This Insight Report provides a comprehensive analysis of the global Cholesterol Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cholesterol Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cholesterol Screening market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cholesterol Screening and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cholesterol Screening.

The global Cholesterol Screening market size is projected to grow from US$ 12030 million in 2022 to US$ 16600 million in 2029; it is expected to grow at a CAGR of 4.7% from 2023 to 2029.

Cholesterol screening services allow early detection of the problems related to high cholesterol levels, avoiding complications and increasing the survival chances of patients.

This report presents a comprehensive overview, market shares, and growth opportunities of Cholesterol Screening market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Hospitals
Government Agencies
Accountable Care Organizations (ACOs)
Others

Segmentation by application
Individual
Organization

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ACM Medical Laboratory
Clinical Reference Laboratory
Laboratory of America
Eurofins Scientific
Quest Diagnostics
SYNLAB International
Fresenius Medical Care

Please note: The report will take approximately 2 business days to prepare and deliver.